Biocatalysis and Protein Engineering Centre for Sustainable Synthesis (BioProcess)
Industrial manufacturing is at a turning point. Many conventional production routes rely on non-renewable resources, harmful chemicals and energy-intensive processes. Biocatalysis using engineered enzymes offers a proven solution.
Led by The University of Manchester, in collaboration with AstraZeneca, the Universities of Bristol and York, and leading industrial partners, the Biocatalysis and Protein Engineering Centre for Sustainable Synthesis (BioProcess IDLA) will train the next generation of scientists in the skills needed to realise the full potential of biocatalysis, protein engineering and biomanufacturing for the UK bioeconomy.
Eligibility
Applicants should have, or expect to achieve, at least a 2.1 honours degree or a master’s (or international equivalent) in a relevant science or engineering related discipline.
How to apply
Applications have closed for start in September 2026, however we will be advertising opportunities for 2027 entry in Autumn/Winter 2026.
Specific projects (based at the Universities of Manchester, York or Bristol) will be announced at which stage interested candidates will be able to select their preferred projects and contact supervisory teams.
By submitting an expression of interest, you will be added to our mailing list to receive an update when specific projects and supervisory teams go live.
Training
BioProcess aims to train the next generation of bio-innovators. Our interdisciplinary programmes prepare PhD students and researchers with the real-world skills to apply biocatalysis, protein engineering and sustainable manufacturing in industry.
We offer:
- PhD projects co-developed with industry and aligned with real manufacturing challenges
- Advanced theoretical and practical skills training provided by a mixture of industry and academic project partners covering structural biology; biophysical and analytical methods; computational modelling; directed evolution; process modelling and development; and digital skills
- Access to a network of elite partners and mentors
- A strong track record of impact, including a free online course in industrial biotechnology with over 10,000 learners to date.
Strong foundations in biocatalysis
Formerly CoEBio3, our centre has a focus on delivering solutions with real impact in pharmaceutical and chemical manufacturing with our industry partners. Our work has already enabled major industrial advances.
-
Commercialised over 1,000 enzymes
Covering 20+ reaction types, significantly expanding biocatalytic options for manufacturing.
-
Pioneered metal-free processes
Reducing reliance on costly and hazardous precious metal catalysts.
-
Delivered high-performing biocatalysts
Engineered industry-ready enzymes suitable for large scale pharmaceutical manufacturing.
Get in touch
If you have a question or are interested in finding out more about the BioProcess IDLA, get in touch.



